<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A high incidence of antibody to asialo GM1 was observed in the sera from the patients with <z:hpo ids='HP_0002725'>Systemic Lupus Erythematosus</z:hpo> (SLE) and <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease with neurological manifestations, using Enzyme Linked Immunosorbent Assay (ELISA), and Thin-layer Chromatography (TLC) immunostaining </plain></SENT>
<SENT sid="1" pm="."><plain>The sera from 60 out of 102 cases of SLE with <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> and 6 out of 10 patients with neuro <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease showed antibody activity against asialo GM1 but not against the asialo GM2, GM1 and galactocerebroside </plain></SENT>
<SENT sid="2" pm="."><plain>In 7 out of 123 cases SLE having a history without neurological manifestations and 1 out of 19 Behçet's patients without <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e>, antiasialo GM1 antibody could be detectable </plain></SENT>
<SENT sid="3" pm="."><plain>However, sera from the patients with other <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, such as RA (60 cases) and P S S (32 cases) or from <z:mpath ids='MPATH_458'>normal</z:mpath> subjects did not show any antibody activity against asialo GM1 </plain></SENT>
<SENT sid="4" pm="."><plain>Antiasialo GM1 antibody activity presents in both IgM and IgG immunoglobulin classes by class specific ELISA and TLC immunostaining </plain></SENT>
<SENT sid="5" pm="."><plain>These studies suggest that detection of antiasialo GM1 antibody may be useful in clinical diagnosis and these autoantibody plays a important role in the pathogenesis of neurological manifestations accompanying SLE and Neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>